Kahn JS; Kesebir D; Cotmore SF; in sod. (2008). »Seroepidemiology of human bocavirus defined using recombinant virus-like particles«. J. Infect. Dis. 198 (1): 41–50. doi:10.1086/588674. PMID18491974.
Corcoran A; Doyle S (2004). »Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19«. J Med Microbiol. 53 (Pt 6): 459–75. doi:10.1099/jmm.0.05485-0. PMID15150324.
Lehmann HW; von Landenberg P; Modrow S (2003). »Parvovirus B19 infection and autoimmune disease«. Autoimmun Rev. 2 (4): 218–223. doi:10.1016/S1568-9972(03)00014-4. PMID12848949.
Kahn JS; Kesebir D; Cotmore SF; in sod. (2008). »Seroepidemiology of human bocavirus defined using recombinant virus-like particles«. J. Infect. Dis. 198 (1): 41–50. doi:10.1086/588674. PMID18491974.
Corcoran A; Doyle S (2004). »Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19«. J Med Microbiol. 53 (Pt 6): 459–75. doi:10.1099/jmm.0.05485-0. PMID15150324.
Lehmann HW; von Landenberg P; Modrow S (2003). »Parvovirus B19 infection and autoimmune disease«. Autoimmun Rev. 2 (4): 218–223. doi:10.1016/S1568-9972(03)00014-4. PMID12848949.
Ballou WR; Reed JL; Noble W; Young NS; Koenig S (2003). »Safety and immunogenicity of a recombinant parvovirus B19 vaccine formulated with MF59C.1«. J Infect Dis. PMID12599085.